Could Protons and Carbon Ions Be the Silver Bullets Against Pancreatic Cancer?

Camille Huart1, Jia-Wei Chen1, Benjamin Le Calvé1

  • 1Unité de Recherche en Biologie Cellulaire (URBC), Namur Research Institute for Life Sciences (NARILIS), University of Namur, 5000 Namur, Belgium.

Insights

Charged particle therapy shows promise for treating pancreatic cancer, a highly aggressive disease with poor survival rates. This approach may overcome treatment resistance, offering a new therapeutic avenue for patients.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Cancer Therapy

Background:

  • Pancreatic cancer is characterized by aggressive progression and poor patient prognostics.
  • Current therapeutic strategies have yielded limited improvements in survival rates.
  • Tumor resistance mechanisms and microenvironment remodeling contribute to treatment failure.

Purpose of the Study:

  • To review the potential of charged particle therapy for pancreatic cancer.
  • To explore how charged particles can overcome established resistance mechanisms.
  • To highlight advancements in radiotherapy for pancreatic cancer treatment.

Main Methods:

  • Literature review on pancreatic cancer treatment resistance.
  • Analysis of modern radiotherapy techniques, specifically charged particle therapy.
  • Evaluation of charged particle interactions with pancreatic tumors and their microenvironment.

Main Results:

  • Charged particle therapy offers enhanced conformational accuracy and tumor-specific effects.
  • This modality presents a potential strategy to counteract tumor resistance mechanisms.
  • Charged particles may provide a more effective alternative to conventional radiotherapy.

Conclusions:

  • Charged particle therapy is a promising approach for pancreatic cancer.
  • Further research is warranted to integrate this modality into clinical practice.
  • This therapy could significantly impact pancreatic cancer treatment outcomes.